Frank McGrew is a Cardiology physician. OpenAlex indexes 55 publications with 2,462 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8060 Wolf River Blvd
Memphis, TN 381381727
Telephone
901-271-1000Registry record last updated 8 Jul 2007.
Clinical trials
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Sponsor: Abbott Medical Devices
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202512 payments
- Medtronic, Inc.Program year202517 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year202523 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.3%Statin14.1%Rosuvastatin Calcium58%Atorvastatin Calcium38%Simvastatin4%Pravastatin Sodium1%Part D<11 patientsBeta blocker10.9%Metoprolol Succinate41%Carvedilol29%Metoprolol Tartrate20%Sotalol5%Nebivolol Hcl2%Atenolol1%Propranolol Hcl1%Part D<11 patients+ 28 more classes in this area
Blood & clotting
11.2%Factor Xa inhibitor5%Eliquis76%Xarelto24%Part D≥127 patientsP2Y12 inhibitor4%Clopidogrel83%Prasugrel Hcl14%Brilinta3%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
8.1%Potassium supplement2.2%Potassium Chloride100%Part D≥90 patientsSGLT2 inhibitor2.1%Farxiga50%Jardiance47%Dapagliflozin4%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM
Journal of the American Heart Association
2024 - THE CLINICAL APPLICATION OF SYNCHRONIZED TRANSVENOUS AND LEADLESS TRANSCATHETER PACING SYSTEMS; A FUTURE OF POSSIBILITIES
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”